ME
Maud Eijkenboom
Ceo, Director at Lixa
View Maud's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Ceo, Director
Nov 2021 - Present · 3 years and 1 months
West Australian Pharmaceuticals
Director
Nov 2004 - Present · 20 years and 1 months
Non Executive Director
Feb 2019 - Present · 5 years and 10 months
Company Details
2-10 Employees
LIXA is focused on developing scalable antibiofilm technologies to treat antimicrobial resistance (AMR), for anyone, anything and anywhere. Our technologies disrupt both mature and immature biofilms and are compatible with most existing antimicrobials. We are open to partnerships to develop real solutions to AMR.
Website
Year Founded
2021
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
22 Stirling Hwy
Nedlands, Western Australia 6009, AU
Keywords
AntibiofilmAntimicrobialBacterial resistanceAMRanti-infectionEquitable healthAntifoulingCompatible to antimicrobialsNon-antibioticSilent pandemic
Contact Details
- Email AddressM**@lixa.lifeReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Maud Eijkenboom in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.